Creador exits Indian pharma player to ChrysCapital
Creador has completed a third exit – with a 3.7x multiple and a 32% IRR – from its third South and Southeast Asia-focused fund, selling a minority position in Indian pharmaceutical company Corona Remedies to ChrysCapital.
ChrysCapital paid INR6.7 billion ($90 million) for a 30% stake, of which 20% came from Creador and 10% from the promoter group, The Economic Times reported ahead of the official announcement. VCCircle...
More on South Asia
Latest News
China home fitness brand Fiture raises $300m
Fiture, a Chinese developer of artificial intelligence-enabled home fitness devices, has raised $300 million in Series B funding led by All-Stars Investment, Legend Capital, DST Global, and Coatue Management.
Temasek leads $200m Series E for China's Arrail Dental
Arrail Group, one of China’s largest dental services providers, has raised close to $200 million in Series E funding led by Temasek Holdings.
China's TuSimple trades flat after $1.3b US IPO
TuSimple, a China and US-based developer of autonomous driving technology for trucks, traded flat on debut following a $1.35 billion IPO at a market capitalization of $8.5 billion.
Alpha JWC seeks $250m for third Indonesia VC fund
Alpha JWC Ventures is targeting $250 million for its third Indonesia-focused venture capital fund, with the International Finance Corporation (IFC) proposing a commitment of up to $20 million.